Co-developing theatre on sensitive subjects: How-to guide launch

Co-developing theatre on sensitive subjects: How-to guide launch

Join us for this webinar to launch a new how-to guide to co-developed theatre as a format for disseminating research on sensitive subjects.

By NIHR Bristol Biomedical Research Centre

Date and time

Thursday, May 15 · 5:30 - 6:30am PDT

Location

Online

About this event

  • Event lasts 1 hour

Theatre can be a powerful way to bring research to life for audiences who might not normally engage with research. But if the research is on a sensitive subject, such as domestic abuse, theatre like this must be produced with care.

At this webinar we will launch a how-to guide for researchers, theatre-makers and public contributors. It’s based on our experiences and evaluation of the play Hard Evidence.

Hard Evidence was co-created with survivors of domestic abuse who were also public contributors on a study, alongside community theatre makers and researchers.

The play aimed to:

  • Highlight the importance of patient and public involvement (PPI) in disseminating research on sensitive subjects
  • Raise awareness of domestic abuse

In this webinar, hear from the team behind the play and the how-to guide, including:

  • Researchers Natalia Lewis, Noreen Hopewell-Kelly and Cat Papastavrou Brooks
  • Alison and Shass, survivors of domestic abuse and public contributors who co-wrote and performed the play
  • Ingrid Jones, theatre maker and Associate Director at acta community theatre

Attendees will get a link to download the full how-to guide.


Organized by

The National Institute for Health and Care Research Bristol Biomedical Research Centre (NIHR Bristol BRC) is a partnership between University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. We are one of 20 BRCs across England funded by the National Institute for Health and Care Research (NIHR).

The Bristol BRC launched in April 2017. We conduct innovative biomedical research to drive through improvements in health and healthcare and encourage closer working with industry.